US5364632A
(en)
*
|
1989-04-05 |
1994-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Medicinal emulsions
|
ZA927277B
(en)
*
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
DE69629230D1
(de)
*
|
1995-03-24 |
2003-09-04 |
Ocular Res Of Bonton Inc |
Hydrogellinse mit Lipid-Vorbeschichtigung
|
DE19511322C2
(de)
|
1995-03-28 |
1999-09-02 |
Mann Gerhard Chem Pharm Fab |
Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
|
US5616342A
(en)
*
|
1995-04-11 |
1997-04-01 |
Pdt, Inc. |
Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
|
DE19527132A1
(de)
*
|
1995-07-25 |
1997-01-30 |
Laevosan Gmbh & Co Kg |
Ophthalmologische Ozonschutzzusammensetzung
|
US5696166A
(en)
*
|
1995-10-31 |
1997-12-09 |
Yanni; John M. |
Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
|
JPH10218760A
(ja)
*
|
1997-02-04 |
1998-08-18 |
Nobel Igaku Kenkyusho:Kk |
ドライアイ治療用の微量油添加目薬
|
ZA989513B
(en)
|
1997-10-21 |
1999-04-21 |
Alcon Lab Inc |
Compositions containing histamine H2 agonists and methods of use in treating dry eye
|
RU2125427C1
(ru)
*
|
1998-05-27 |
1999-01-27 |
Миронова Эмилия Михайловна |
Средство для лечения глазных заболеваний - оковидит
|
EP0982025A1
(en)
*
|
1998-08-28 |
2000-03-01 |
Wilhelm Prof. Dr. Stoffel |
Synthetic tear fluid
|
AU2183900A
(en)
|
1998-12-24 |
2000-07-31 |
Alcon Laboratories, Inc. |
Ep4 receptor agonists for treatment of dry eye
|
WO2000038690A2
(en)
|
1998-12-24 |
2000-07-06 |
Alcon Laboratories, Inc. |
Prostaglandin e agonists for treatment of dry eye
|
EP1156809B1
(en)
|
1999-03-01 |
2005-12-07 |
Vista Scientific LLC |
Mucin containing ophthalmic preparations
|
AUPQ228199A0
(en)
*
|
1999-08-18 |
1999-09-09 |
Sly, Anthony William |
Ophthalmic fluid
|
WO2001034552A2
(en)
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
|
AU775290B2
(en)
|
1999-11-09 |
2004-07-29 |
Alcon Inc. |
Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
|
US6803385B2
(en)
|
1999-11-09 |
2004-10-12 |
Alcon, Inc. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
WO2001034144A1
(en)
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
Lipoxin a4 and its analogs for the treatment of dry eye
|
AU8031400A
(en)
|
1999-11-09 |
2001-06-06 |
Alcon Universal Limited |
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
|
BR0015404A
(pt)
|
1999-11-09 |
2002-06-25 |
Alcon Inc |
Compostos relacionados com ácido 15-hidroxieicosatetraenóico e métodos de uso
|
WO2001034553A2
(en)
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
|
WO2001034129A2
(en)
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
|
DK1228028T3
(da)
|
1999-11-09 |
2005-11-14 |
Alcon Inc |
Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser
|
US6458854B2
(en)
|
1999-11-09 |
2002-10-01 |
Alcon Universal Ltd. |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
|
CN1387505A
(zh)
|
1999-11-09 |
2002-12-25 |
爱尔康公司 |
含羟基二十碳四烯酸衍生物的组合物和用于治疗干眼病的方法
|
ES2215740T3
(es)
|
1999-11-09 |
2004-10-16 |
Alcon Inc. |
Homologos de 15-hete con sustitucion 3-heteroatomica y dos carbonos, y metodo de uso.
|
US6552084B2
(en)
|
1999-11-09 |
2003-04-22 |
Alcon Universal Ltd. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
AU1226001A
(en)
|
1999-11-09 |
2001-06-06 |
Alcon Universal Limited |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
|
AU2603301A
(en)
|
1999-12-22 |
2001-07-03 |
Alcon Universal Limited |
6-keto prostaglandin F1alpha and analogs for treating dry eye
|
US6348508B1
(en)
|
2000-04-04 |
2002-02-19 |
Bausch & Lomb Incorporated |
Method for treating dry eye
|
US7524511B1
(en)
|
2000-07-12 |
2009-04-28 |
Rogue Valley Natural Springs, Inc. |
Method and kit for moisturizing the surface of the eye
|
JP2004502497A
(ja)
*
|
2000-07-12 |
2004-01-29 |
ルージュ ヴァリー ナチュラル スプリングス インコーポレイテッド |
眼の表面を湿らせる方法及びキット
|
JP2004531560A
(ja)
*
|
2001-05-21 |
2004-10-14 |
アルコン,インコーポレイテッド |
ドライアイ障害を処置する方法
|
US6872382B1
(en)
|
2001-05-21 |
2005-03-29 |
Alcon, Inc. |
Use of selective PDE IV inhibitors to treat dry eye disorders
|
DK1392355T3
(da)
|
2001-05-21 |
2007-04-30 |
Alcon Inc |
Anvendelse af proteasominhibitorer tilbehandling af öjentörhedslidelser
|
PL367286A1
(en)
|
2001-05-21 |
2005-02-21 |
Alcon, Inc. |
Use of nfkb inhibitors to treat dry eye disorders
|
US7112588B2
(en)
*
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
US6645994B1
(en)
|
2001-06-01 |
2003-11-11 |
Alcon, Inc. |
Method of treating dry eye disorders
|
FR2827190A1
(fr)
*
|
2001-06-22 |
2003-01-17 |
Rhodia Chimie Sa |
Utilisation d'une huile comprenant un groupement polaire comme aide au depot d'une huile polaire non ionisable
|
US6750250B1
(en)
*
|
2001-07-12 |
2004-06-15 |
Alcon, Inc. |
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
|
DE10141018A1
(de)
*
|
2001-08-22 |
2003-03-13 |
Eth Zuerich Eidgenoessische Te |
Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
|
US20040214754A1
(en)
*
|
2001-10-03 |
2004-10-28 |
Ellis Edward J. |
Ophthalmic preparation containing glycomacropeptide
|
US20040220089A1
(en)
*
|
2001-10-03 |
2004-11-04 |
Ellis Edward J. |
Ophthalmic preparation containing glycoprotein
|
US20030109508A1
(en)
*
|
2001-10-11 |
2003-06-12 |
Alcon, Inc. |
Methods for treating dry eye
|
US20030109509A1
(en)
*
|
2001-10-11 |
2003-06-12 |
Alcon, Inc. |
Methods for treating dry eye
|
US6656460B2
(en)
*
|
2001-11-01 |
2003-12-02 |
Yissum Research Development |
Method and composition for dry eye treatment
|
AU782913B2
(en)
*
|
2001-11-02 |
2005-09-08 |
Santen Sas |
Method and composition for dry eye treatment
|
CA2484512C
(en)
*
|
2002-05-17 |
2013-04-16 |
Othera Pharmaceuticals, Inc. |
Treatment of cataracts and other ophthalmic diseases
|
EP1542768A1
(en)
*
|
2002-09-20 |
2005-06-22 |
Alcon, Inc. |
Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
|
WO2004060274A2
(en)
*
|
2002-12-20 |
2004-07-22 |
Alcon, Inc. |
Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
|
WO2004093878A1
(en)
|
2003-04-16 |
2004-11-04 |
Alcon, Inc. |
Use of fused pyridazine derivatives for treating dry eye disorders
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
CN100464786C
(zh)
*
|
2003-09-10 |
2009-03-04 |
千寿制药株式会社 |
隐形眼镜用眼科用组合物
|
MXPA03011987A
(es)
|
2003-12-19 |
2005-06-23 |
Osio Sancho Alberto |
Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
|
CA2552524A1
(en)
*
|
2004-01-10 |
2005-07-28 |
Biolipid, Inc. |
Lipid compositions and methods of use
|
US20050182039A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Bausch & Lomb Incorporated |
Use of Loteprednol etabonate for the treatment of dry eye
|
DE602005016392D1
(de)
|
2004-03-25 |
2009-10-15 |
Bausch & Lomb |
Verwendung von loteprednoletabonat zur behanldung von trockenen augen
|
JP4993299B2
(ja)
*
|
2004-05-14 |
2012-08-08 |
アルコン,インコーポレイテッド |
ドライアイ障害およびブドウ膜炎を処置するための方法
|
US7923471B2
(en)
*
|
2004-05-14 |
2011-04-12 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
JP2008505177A
(ja)
*
|
2004-07-01 |
2008-02-21 |
ザ・シェペンズ・アイ・リサーチ・インスティテュート・インコーポレーテッド |
目の障害および状態を治療するための組成物および方法
|
WO2006009112A1
(ja)
*
|
2004-07-16 |
2006-01-26 |
Taisho Pharmaceutical Co., Ltd. |
水性点眼剤
|
US7223737B1
(en)
|
2004-08-13 |
2007-05-29 |
Alcon, Inc. |
Method of treating dry eye disorders using glycosides
|
KR20070061537A
(ko)
|
2004-08-27 |
2007-06-13 |
센주 세이야꾸 가부시키가이샤 |
건성안 치료용 안약액
|
WO2006065916A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Alcon, Inc. |
Method of treating dry eye disorders using 13(s)-hode and its analogs
|
AU2012201476B2
(en)
*
|
2005-01-12 |
2014-07-17 |
Ocular Research Of Boston, Inc |
Dry eye treatment
|
US9161905B2
(en)
*
|
2005-01-12 |
2015-10-20 |
Ocular Research Of Boston, Inc. |
Dry eye treatment
|
TW200722109A
(en)
*
|
2005-03-31 |
2007-06-16 |
Bausch & Lomb |
Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
|
TWI393567B
(zh)
*
|
2005-03-31 |
2013-04-21 |
Bausch & Lomb |
治療乾眼之組合物及相關之製造方法及使用方法
|
DK2564843T3
(en)
|
2005-06-01 |
2019-03-11 |
Bioelectron Tech Corp |
Redox-active therapeutics for the treatment of mitochondrial diseases and other conditions as well as modulation of energy biomarkers
|
US20070004672A1
(en)
*
|
2005-07-01 |
2007-01-04 |
Dharmendra Jani |
Long lasting alginate dry eye, related methods of manufacture and methods of use
|
US20070110812A1
(en)
*
|
2005-11-14 |
2007-05-17 |
Bausch & Lomb Incorporated |
Ophthalmic composition for dry eye therapy
|
JP6033177B2
(ja)
*
|
2006-01-13 |
2016-11-30 |
大正製薬株式会社 |
O/w型エマルション水性点眼剤
|
JP5748385B2
(ja)
*
|
2006-01-13 |
2015-07-15 |
大正製薬株式会社 |
O/w型エマルション水性点眼剤
|
JP5374162B2
(ja)
|
2006-02-22 |
2013-12-25 |
エジソン ファーマシューティカルズ, インコーポレイテッド |
ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
|
US7745461B1
(en)
|
2006-02-27 |
2010-06-29 |
Alcon Research, Ltd. |
Method of treating dry eye disorders
|
ES2284398B2
(es)
|
2006-04-27 |
2008-12-16 |
Universidad Complutense De Madrid |
Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
|
US7691811B2
(en)
*
|
2006-05-25 |
2010-04-06 |
Bodor Nicholas S |
Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
|
EP2051736A2
(en)
*
|
2006-07-07 |
2009-04-29 |
Bausch & Lomb Incorporated |
Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye
|
US20080057022A1
(en)
*
|
2006-08-30 |
2008-03-06 |
Erning Xia |
Ophthalmic Pharmaceutical Compositions and Uses Thereof
|
US20080095754A1
(en)
*
|
2006-10-18 |
2008-04-24 |
Burke Susan E |
Ophthalmic compositions comprising diglycine
|
US8138156B2
(en)
*
|
2006-10-18 |
2012-03-20 |
Bausch & Lomb Incorporated |
Ophthalmic compositions containing diglycine
|
WO2008052037A2
(en)
*
|
2006-10-24 |
2008-05-02 |
Alcon Research, Ltd. |
Packaging materials for formulations containing 2-pyrrolidone derivatives
|
US20080095863A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Alcon Manufacturing Ltd. |
2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions
|
US20080188573A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Alcon Research, Ltd. |
Use of thy1-fp transgenic mouse for the identification of ophthalmic agents
|
WO2008120249A1
(en)
*
|
2007-03-30 |
2008-10-09 |
Sifi S.P.A. |
Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
|
ES2396999T3
(es)
*
|
2007-05-04 |
2013-03-01 |
Bausch & Lomb Incorporated |
Composiciones para la reducción, mejora, tratamiento, o prevención de la afección de ojo seco y métodos de elaboración y de uso de las mismas
|
CA2686866A1
(en)
*
|
2007-05-07 |
2008-11-13 |
Erning Xia |
Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
|
WO2008154129A1
(en)
*
|
2007-06-08 |
2008-12-18 |
Bausch & Lomb Incorporated |
Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye
|
US20090142292A1
(en)
*
|
2007-12-03 |
2009-06-04 |
Blackwell Richard I |
Method For The Mitigation of Symptoms of Dry Eye
|
US8629099B2
(en)
*
|
2008-03-25 |
2014-01-14 |
Bausch & Lomb Incorporated |
Ophthalmic compositions comprising a dipeptide
|
US8314153B2
(en)
|
2008-09-10 |
2012-11-20 |
Edison Pharmaceuticals, Inc. |
Treatment of pervasive developmental disorders with redox-active therapeutics
|
WO2010030725A1
(en)
*
|
2008-09-15 |
2010-03-18 |
Bausch & Lomb Incorporated |
Compositions comprising polymers having amino sugar units and methods of making and using same
|
US8539938B2
(en)
*
|
2009-03-12 |
2013-09-24 |
Ford Global Technologies, Llc |
Fuel systems and methods for controlling fuel systems in a vehicle with multiple fuel tanks
|
EA031126B1
(ru)
|
2009-04-28 |
2018-11-30 |
Биоэлектрон Текнолоджи Корпорейшн |
Способ лечения доминантной атрофии зрительного нерва токотриенол-хинонами
|
TWI478730B
(zh)
|
2009-12-03 |
2015-04-01 |
Alcon Res Ltd |
眼科乳劑
|
US8658614B2
(en)
|
2010-08-13 |
2014-02-25 |
The University of Texas Health Science Center |
Aptamer-containing compositions and methods for targeting E-selectin
|
US9161531B2
(en)
|
2011-02-23 |
2015-10-20 |
Donald R. Korb |
High alcohol content sanitizer
|
US8859525B2
(en)
|
2011-07-19 |
2014-10-14 |
Bausch & Lomb Incorporated |
Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
|
EP2758031A1
(en)
|
2011-09-22 |
2014-07-30 |
Bausch & Lomb Incorporated |
Ophthalmic gel compositions
|
US8664180B2
(en)
|
2012-02-06 |
2014-03-04 |
Bausch & Lomb Incorporated |
Ophthalmic compositions containing diglycine
|
US8324171B1
(en)
|
2012-02-06 |
2012-12-04 |
Bausch & Lomb Incorporated |
Ophthalmic compositions containing diglycine
|
US9278132B2
(en)
|
2012-02-13 |
2016-03-08 |
Bausch & Lomb Incorporated |
Ophthalmic pharmaceutical compositions and methods of making and using same
|
KR101726029B1
(ko)
|
2012-02-24 |
2017-04-11 |
보오슈 앤드 롬 인코포레이팃드 |
알콕실화된 천연 왁스를 갖는 안과용 조성물
|
JP6016465B2
(ja)
*
|
2012-06-12 |
2016-10-26 |
ロート製薬株式会社 |
ビタミンa類を含有する水性組成物
|
RU2647783C2
(ru)
|
2012-08-10 |
2018-03-19 |
Осио Корпорейшн Д/Б/А Иолиа Хелт |
Использование контактных линз при лечении офтальмологического нарушения
|
EP2948196B1
(en)
|
2013-01-24 |
2017-08-23 |
Bausch & Lomb Incorporated |
Poly(nitrogen/amine) derivatives of a natural wax or an alkoxylated derivative thereof and ophthalmic compositions
|
WO2015138604A1
(en)
|
2014-03-12 |
2015-09-17 |
University Of Virginia Patent Foundation |
Compositions and methods for treating eye infections and disease
|
WO2015171516A1
(en)
|
2014-05-05 |
2015-11-12 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to ionic salts of peptides
|
CN107074884A
(zh)
|
2014-06-18 |
2017-08-18 |
西蒂斯制药有限责任公司 |
活性剂的矿物质氨基酸复合物
|
WO2017079734A1
(en)
|
2015-11-05 |
2017-05-11 |
University Of Louisville Research Foundation, Inc. |
Local and regional anesthesia and analgesia
|
CN108712903A
(zh)
|
2015-12-17 |
2018-10-26 |
生物电子技术有限公司 |
用于治疗氧化应急障碍的氟烷基、氟代烷氧基、苯氧基、杂芳氧基、烷氧基和胺1,4-苯醌衍生物
|
CA3026264A1
(en)
|
2016-06-03 |
2017-12-07 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to salts of specialized pro-resolving mediators
|
US9981041B2
(en)
|
2016-08-23 |
2018-05-29 |
Ira Jason Salzman |
Ophthalmic lubricating spray
|
US20180296390A1
(en)
*
|
2017-04-18 |
2018-10-18 |
David Hoare |
Apparatus and method for treating a number of eye conditions of a user including dry eye syndrome and/or burns to the eyes
|
TW201938141A
(zh)
|
2018-02-21 |
2019-10-01 |
瑞士商諾華公司 |
基於脂質的眼用乳劑
|
US11147737B2
(en)
|
2018-02-26 |
2021-10-19 |
Olympic Ophthalmics, Inc. |
Handheld device with motorized member for treatment of disorders
|
US11278493B2
(en)
|
2018-12-10 |
2022-03-22 |
EternaTear, Inc. |
Ophthalmic formulations providing durable ocular lubrication
|
US11471475B1
(en)
|
2022-03-08 |
2022-10-18 |
Ralph P. Stone |
Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
|
US11679078B1
(en)
|
2022-03-08 |
2023-06-20 |
EternaTear, Inc. |
Ophthalmic formulations and related methods
|